- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2867
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Temozolomide promotes genomic and phenotypic changes in glioblastoma cells ; volume:16 ; number:1 ; day:5 ; month:5 ; year:2016 ; pages:1-16 ; date:12.2016
Cancer cell international ; 16, Heft 1 (5.5.2016), 1-16, 12.2016
- Creator
-
Stepanenko, Aleksei A.
- Contributor
-
Andreieva, Svitlana V.
Korets, Kateryna V.
Mykytenko, Dmytro O.
Baklaushev, Vladimir P.
Huleyuk, Nataliya L.
Kovalova, Oksana A.
Kotsarenko, Kateryna V.
Chekhonin, Vladimir P.
Vassetzky, Yegor S.
Avdieiev, Stanislav S.
Dmitrenko, Vladimir V.
SpringerLink (Online service)
- DOI
-
10.1186/s12935-016-0311-8
- URN
-
urn:nbn:de:1111-201605071388
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Stepanenko, Aleksei A.
- Andreieva, Svitlana V.
- Korets, Kateryna V.
- Mykytenko, Dmytro O.
- Baklaushev, Vladimir P.
- Huleyuk, Nataliya L.
- Kovalova, Oksana A.
- Kotsarenko, Kateryna V.
- Chekhonin, Vladimir P.
- Vassetzky, Yegor S.
- Avdieiev, Stanislav S.
- Dmitrenko, Vladimir V.
- SpringerLink (Online service)
Other Objects (12)
p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme
Stanniocalcin-1 promotes temozolomide resistance of glioblastoma through regulation of MGMT
TTK Protein Kinase promotes temozolomide resistance through inducing autophagy in glioblastoma
A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma
Accelerated hyperfractionation plus temozolomide in glioblastoma
DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma
ADAR3 activates NF-κB signaling and promotes glioblastoma cell resistance to temozolomide
RPL22L1, a novel candidate oncogene promotes temozolomide resistance by activating STAT3 in glioblastoma
Exosome-transmitted circCABIN1 promotes temozolomide resistance in glioblastoma via sustaining ErbB downstream signaling
Temozolomide promotes matrix metalloproteinase 9 expression through p38 MAPK and JNK pathways in glioblastoma cells
The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells
Considering the experimental use of temozolomide in glioblastoma research
p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme
Stanniocalcin-1 promotes temozolomide resistance of glioblastoma through regulation of MGMT
TTK Protein Kinase promotes temozolomide resistance through inducing autophagy in glioblastoma
A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma
Accelerated hyperfractionation plus temozolomide in glioblastoma
DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma
ADAR3 activates NF-κB signaling and promotes glioblastoma cell resistance to temozolomide
RPL22L1, a novel candidate oncogene promotes temozolomide resistance by activating STAT3 in glioblastoma
Exosome-transmitted circCABIN1 promotes temozolomide resistance in glioblastoma via sustaining ErbB downstream signaling
Temozolomide promotes matrix metalloproteinase 9 expression through p38 MAPK and JNK pathways in glioblastoma cells
The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells
Considering the experimental use of temozolomide in glioblastoma research
p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme
Stanniocalcin-1 promotes temozolomide resistance of glioblastoma through regulation of MGMT
TTK Protein Kinase promotes temozolomide resistance through inducing autophagy in glioblastoma
A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma
Accelerated hyperfractionation plus temozolomide in glioblastoma
DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma
ADAR3 activates NF-κB signaling and promotes glioblastoma cell resistance to temozolomide
RPL22L1, a novel candidate oncogene promotes temozolomide resistance by activating STAT3 in glioblastoma
Exosome-transmitted circCABIN1 promotes temozolomide resistance in glioblastoma via sustaining ErbB downstream signaling
Temozolomide promotes matrix metalloproteinase 9 expression through p38 MAPK and JNK pathways in glioblastoma cells
The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells